Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 901 to 908 of 908 entries
Sorted by: Best Match Show Resources per page
Photoinduced Water Oxidation in Chitosan Nanostructures Containing Covalently Linked Ru.

Chemistry (Weinheim an der Bergstrasse, Germany)

La Ganga G, Puntoriero F, Fazio E, Natali M, Nastasi F, Santoro A, Galletta M, Campagna S.
PMID: 34418201
Chemistry. 2021 Dec 06;27(68):16904-16911. doi: 10.1002/chem.202102032. Epub 2021 Sep 23.

The luminophore Ru(bpy)

Cite
La Ganga G, Puntoriero F, Fazio E, et al. Photoinduced Water Oxidation in Chitosan Nanostructures Containing Covalently Linked Ru. Chemistry. 2021;27(68):16904-16911doi: 10.1002/chem.202102032.
La Ganga, G., Puntoriero, F., Fazio, E., Natali, M., Nastasi, F., Santoro, A., Galletta, M., & Campagna, S. (2021). Photoinduced Water Oxidation in Chitosan Nanostructures Containing Covalently Linked Ru. Chemistry (Weinheim an der Bergstrasse, Germany), 27(68), 16904-16911. https://doi.org/10.1002/chem.202102032
La Ganga, Giuseppina, et al. "Photoinduced Water Oxidation in Chitosan Nanostructures Containing Covalently Linked Ru." Chemistry (Weinheim an der Bergstrasse, Germany) vol. 27,68 (2021): 16904-16911. doi: https://doi.org/10.1002/chem.202102032
La Ganga G, Puntoriero F, Fazio E, Natali M, Nastasi F, Santoro A, Galletta M, Campagna S. Photoinduced Water Oxidation in Chitosan Nanostructures Containing Covalently Linked Ru. Chemistry. 2021 Dec 06;27(68):16904-16911. doi: 10.1002/chem.202102032. Epub 2021 Sep 23. PMID: 34418201.
Copy Download .nbib Format: NLM
Weibull Modeling of Controlled Drug Release from Ag-PMA Nanosystems.

Polymers

Corsaro C, Neri G, Mezzasalma AM, Fazio E.
PMID: 34502937
Polymers (Basel). 2021 Aug 27;13(17). doi: 10.3390/polym13172897.

Traditional pharmacotherapy suffers from multiple drawbacks that hamper patient treatment such as antibiotic resistances or low drug selectivity and toxicity during systemic applications. Some functional hybrid nanomaterials are designed to handle the drug release process under remote-control. More attention...

Cite
Corsaro C, Neri G, Mezzasalma AM, et al. Weibull Modeling of Controlled Drug Release from Ag-PMA Nanosystems. Polymers (Basel). 2021;13(17)doi: 10.3390/polym13172897.
Corsaro, C., Neri, G., Mezzasalma, A. M., & Fazio, E. (2021). Weibull Modeling of Controlled Drug Release from Ag-PMA Nanosystems. Polymers, 13(17), . https://doi.org/10.3390/polym13172897
Corsaro, Carmelo, et al. "Weibull Modeling of Controlled Drug Release from Ag-PMA Nanosystems." Polymers vol. 13,17 (2021). doi: https://doi.org/10.3390/polym13172897
Corsaro C, Neri G, Mezzasalma AM, Fazio E. Weibull Modeling of Controlled Drug Release from Ag-PMA Nanosystems. Polymers (Basel). 2021 Aug 27;13(17). doi: 10.3390/polym13172897. PMID: 34502937; PMCID: PMC8434431.
Copy Download .nbib Format: NLM
Adjuvant Chemotherapy for Stage I Pancreatic Ductal Adenocarcinoma-Is It Based on Evidence or Clinical Wisdom?.

JAMA oncology

Gervaso L, Lordick F, Fazio N.
PMID: 34617958
JAMA Oncol. 2021 Dec 01;7(12):1759-1760. doi: 10.1001/jamaoncol.2021.3603.

No abstract available.

Cite
Gervaso L, Lordick F, Fazio N. Adjuvant Chemotherapy for Stage I Pancreatic Ductal Adenocarcinoma-Is It Based on Evidence or Clinical Wisdom?. JAMA Oncol. 2021;7(12):1759-1760doi: 10.1001/jamaoncol.2021.3603.
Gervaso, L., Lordick, F., & Fazio, N. (2021). Adjuvant Chemotherapy for Stage I Pancreatic Ductal Adenocarcinoma-Is It Based on Evidence or Clinical Wisdom?. JAMA oncology, 7(12), 1759-1760. https://doi.org/10.1001/jamaoncol.2021.3603
Gervaso, Lorenzo, et al. "Adjuvant Chemotherapy for Stage I Pancreatic Ductal Adenocarcinoma-Is It Based on Evidence or Clinical Wisdom?." JAMA oncology vol. 7,12 (2021): 1759-1760. doi: https://doi.org/10.1001/jamaoncol.2021.3603
Gervaso L, Lordick F, Fazio N. Adjuvant Chemotherapy for Stage I Pancreatic Ductal Adenocarcinoma-Is It Based on Evidence or Clinical Wisdom?. JAMA Oncol. 2021 Dec 01;7(12):1759-1760. doi: 10.1001/jamaoncol.2021.3603. PMID: 34617958.
Copy Download .nbib Format: NLM
Investigation of polyacrylamide hydrogel-based molecularly imprinted polymers using protein gel electrophoresis.

Journal of molecular recognition : JMR

El Sharif HF, Giosia F, Reddy SM.
PMID: 34697843
J Mol Recognit. 2022 Jan;35(1):e2942. doi: 10.1002/jmr.2942. Epub 2021 Oct 25.

In conjunction with polyacrylamide gel electrophoresis (PAGE), molecular imprinting methods have been applied to produce a multilayer mini-slab in order to evaluate how selectively and specifically a hydrogel-based molecularly imprinted polymer (MIP) binds bovine haemoglobin (BHb, ~64.5 kDa). A...

Cite
El Sharif HF, Giosia F, Reddy SM. Investigation of polyacrylamide hydrogel-based molecularly imprinted polymers using protein gel electrophoresis. J Mol Recognit. 2021;35(1):e2942doi: 10.1002/jmr.2942.
El Sharif, H. F., Giosia, F., & Reddy, S. M. (2022). Investigation of polyacrylamide hydrogel-based molecularly imprinted polymers using protein gel electrophoresis. Journal of molecular recognition : JMR, 35(1), e2942. https://doi.org/10.1002/jmr.2942
El Sharif, Hazim F, et al. "Investigation of polyacrylamide hydrogel-based molecularly imprinted polymers using protein gel electrophoresis." Journal of molecular recognition : JMR vol. 35,1 (2022): e2942. doi: https://doi.org/10.1002/jmr.2942
El Sharif HF, Giosia F, Reddy SM. Investigation of polyacrylamide hydrogel-based molecularly imprinted polymers using protein gel electrophoresis. J Mol Recognit. 2022 Jan;35(1):e2942. doi: 10.1002/jmr.2942. Epub 2021 Oct 25. PMID: 34697843.
Copy Download .nbib Format: NLM
Risk of venous and arterial thromboembolic events in women with advanced breast cancer treated with CDK 4/6 inhibitors: A systematic review and meta-analysis.

Thrombosis research

Bolzacchini E, Pomero F, Fazio M, Civitelli C, Fabro G, Pellegrino D, Giordano M, Squizzato A.
PMID: 34814055
Thromb Res. 2021 Dec;208:190-197. doi: 10.1016/j.thromres.2021.11.009. Epub 2021 Nov 17.

BACKGROUND: Cyclin-dependent kinase inhibitors (CDKIs) may increase the risk of thrombotic events of endocrine therapy (ET) in women with hormone-sensitive, HER2-negative advanced breast cancer (BC). Aim of our systematic review is the estimate of the risk of venous and...

Cite
Bolzacchini E, Pomero F, Fazio M, et al. Risk of venous and arterial thromboembolic events in women with advanced breast cancer treated with CDK 4/6 inhibitors: A systematic review and meta-analysis. Thromb Res. 2021;208:190-197doi: 10.1016/j.thromres.2021.11.009.
Bolzacchini, E., Pomero, F., Fazio, M., Civitelli, C., Fabro, G., Pellegrino, D., Giordano, M., & Squizzato, A. (2021). Risk of venous and arterial thromboembolic events in women with advanced breast cancer treated with CDK 4/6 inhibitors: A systematic review and meta-analysis. Thrombosis research, 208190-197. https://doi.org/10.1016/j.thromres.2021.11.009
Bolzacchini, Elena, et al. "Risk of venous and arterial thromboembolic events in women with advanced breast cancer treated with CDK 4/6 inhibitors: A systematic review and meta-analysis." Thrombosis research vol. 208 (2021): 190-197. doi: https://doi.org/10.1016/j.thromres.2021.11.009
Bolzacchini E, Pomero F, Fazio M, Civitelli C, Fabro G, Pellegrino D, Giordano M, Squizzato A. Risk of venous and arterial thromboembolic events in women with advanced breast cancer treated with CDK 4/6 inhibitors: A systematic review and meta-analysis. Thromb Res. 2021 Dec;208:190-197. doi: 10.1016/j.thromres.2021.11.009. Epub 2021 Nov 17. PMID: 34814055.
Copy Download .nbib Format: NLM
Peering into the dark (ages) with low-frequency space interferometers: Using the 21-cm signal of neutral hydrogen from the infant universe to probe fundamental (Astro)physics.

Experimental astronomy

Koopmans LVE, Barkana R, Bentum M, Bernardi G, Boonstra AJ, Bowman J, Burns J, Chen X, Datta A, Falcke H, Fialkov A, Gehlot B, Gurvits L, Jelić V, Klein-Wolt M, Lazio J, Meerburg D, Mellema G, Mertens F, Mesinger A, Offringa A, Pritchard J, Semelin B, Subrahmanyan R, Silk J, Trott C, Vedantham H, Verde L, Zaroubi S, Zarka P.
PMID: 34511720
Exp Astron (Dordr). 2021 Sep 03;1-36. doi: 10.1007/s10686-021-09743-7. Epub 2021 Sep 03.

The Dark Ages and Cosmic Dawn are largely unexplored windows on the infant Universe (z ~ 200-10). Observations of the redshifted 21-cm line of neutral hydrogen can provide valuable new insight into fundamental physics and astrophysics during these eras...

Cite
Koopmans LVE, Barkana R, Bentum M, et al. Peering into the dark (ages) with low-frequency space interferometers: Using the 21-cm signal of neutral hydrogen from the infant universe to probe fundamental (Astro)physics. Exp Astron (Dordr). 2021;1-36doi: 10.1007/s10686-021-09743-7.
Koopmans, L. V. E., Barkana, R., Bentum, M., Bernardi, G., Boonstra, A. J., Bowman, J., Burns, J., Chen, X., Datta, A., Falcke, H., Fialkov, A., Gehlot, B., Gurvits, L., Jelić, V., Klein-Wolt, M., Lazio, J., Meerburg, D., Mellema, G., Mertens, F., Mesinger, A., Offringa, A., Pritchard, J., Semelin, B., Subrahmanyan, R., Silk, J., Trott, C., Vedantham, H., Verde, L., Zaroubi, S., & Zarka, P. (2021). Peering into the dark (ages) with low-frequency space interferometers: Using the 21-cm signal of neutral hydrogen from the infant universe to probe fundamental (Astro)physics. Experimental astronomy, 1-36. https://doi.org/10.1007/s10686-021-09743-7
Koopmans, Léon V E, et al. "Peering into the dark (ages) with low-frequency space interferometers: Using the 21-cm signal of neutral hydrogen from the infant universe to probe fundamental (Astro)physics." Experimental astronomy vol. (2021): 1-36. doi: https://doi.org/10.1007/s10686-021-09743-7
Koopmans LVE, Barkana R, Bentum M, Bernardi G, Boonstra AJ, Bowman J, Burns J, Chen X, Datta A, Falcke H, Fialkov A, Gehlot B, Gurvits L, Jelić V, Klein-Wolt M, Lazio J, Meerburg D, Mellema G, Mertens F, Mesinger A, Offringa A, Pritchard J, Semelin B, Subrahmanyan R, Silk J, Trott C, Vedantham H, Verde L, Zaroubi S, Zarka P. Peering into the dark (ages) with low-frequency space interferometers: Using the 21-cm signal of neutral hydrogen from the infant universe to probe fundamental (Astro)physics. Exp Astron (Dordr). 2021 Sep 03;1-36. doi: 10.1007/s10686-021-09743-7. Epub 2021 Sep 03. PMID: 34511720; PMCID: PMC8416573.
Copy Download .nbib Format: NLM
Step-by-Step Cadaver Dissection and Surgical Technique for Compartmental Tongue and Floor of Mouth Resection.

Frontiers in oncology

Grammatica A, Piazza C, Ferrari M, Verzeletti V, Paderno A, Mattavelli D, Schreiber A, Lombardi D, Fazio E, Gazzini L, Giorgetti G, Buffoli B, Rodella LF, Nicolai P, Calabrese L.
PMID: 33968719
Front Oncol. 2021 Apr 23;11:613945. doi: 10.3389/fonc.2021.613945. eCollection 2021.

BACKGROUND: The aim of oral cancer surgery is tumor removal within clear margins of healthy tissue: the latter definition in the literature, however, may vary between 1 and 2 cm, and should be intended in the three dimensions, which...

Cite
Grammatica A, Piazza C, Ferrari M, et al. Step-by-Step Cadaver Dissection and Surgical Technique for Compartmental Tongue and Floor of Mouth Resection. Front Oncol. 2021;11:613945doi: 10.3389/fonc.2021.613945.
Grammatica, A., Piazza, C., Ferrari, M., Verzeletti, V., Paderno, A., Mattavelli, D., Schreiber, A., Lombardi, D., Fazio, E., Gazzini, L., Giorgetti, G., Buffoli, B., Rodella, L. F., Nicolai, P., & Calabrese, L. (2021). Step-by-Step Cadaver Dissection and Surgical Technique for Compartmental Tongue and Floor of Mouth Resection. Frontiers in oncology, 11613945. https://doi.org/10.3389/fonc.2021.613945
Grammatica, Alberto, et al. "Step-by-Step Cadaver Dissection and Surgical Technique for Compartmental Tongue and Floor of Mouth Resection." Frontiers in oncology vol. 11 (2021): 613945. doi: https://doi.org/10.3389/fonc.2021.613945
Grammatica A, Piazza C, Ferrari M, Verzeletti V, Paderno A, Mattavelli D, Schreiber A, Lombardi D, Fazio E, Gazzini L, Giorgetti G, Buffoli B, Rodella LF, Nicolai P, Calabrese L. Step-by-Step Cadaver Dissection and Surgical Technique for Compartmental Tongue and Floor of Mouth Resection. Front Oncol. 2021 Apr 23;11:613945. doi: 10.3389/fonc.2021.613945. eCollection 2021. PMID: 33968719; PMCID: PMC8104033.
Copy Download .nbib Format: NLM
Home pharmacological therapy in early COVID-19 to prevent hospitalization and reduce mortality: Time for a suitable proposal.

Basic & clinical pharmacology & toxicology

Pandolfi S, Chirumbolo S, Ricevuti G, Valdenassi L, Bjørklund G, Lysiuk R, Doşa MD, Lenchyk L, Fazio S.
PMID: 34811895
Basic Clin Pharmacol Toxicol. 2022 Feb;130(2):225-239. doi: 10.1111/bcpt.13690. Epub 2021 Dec 02.

The COVID-19 pandemic is a highly dramatic concern for mankind. In Italy, the pandemic exerted its major impact throughout the period of February to June 2020. To date, the awkward amount of more than 134,000 deaths has been reported....

Cite
Pandolfi S, Chirumbolo S, Ricevuti G, et al. Home pharmacological therapy in early COVID-19 to prevent hospitalization and reduce mortality: Time for a suitable proposal. Basic Clin Pharmacol Toxicol. 2021;130(2):225-239doi: 10.1111/bcpt.13690.
Pandolfi, S., Chirumbolo, S., Ricevuti, G., Valdenassi, L., Bjørklund, G., Lysiuk, R., Doşa, M. D., Lenchyk, L., & Fazio, S. (2022). Home pharmacological therapy in early COVID-19 to prevent hospitalization and reduce mortality: Time for a suitable proposal. Basic & clinical pharmacology & toxicology, 130(2), 225-239. https://doi.org/10.1111/bcpt.13690
Pandolfi, Sergio, et al. "Home pharmacological therapy in early COVID-19 to prevent hospitalization and reduce mortality: Time for a suitable proposal." Basic & clinical pharmacology & toxicology vol. 130,2 (2022): 225-239. doi: https://doi.org/10.1111/bcpt.13690
Pandolfi S, Chirumbolo S, Ricevuti G, Valdenassi L, Bjørklund G, Lysiuk R, Doşa MD, Lenchyk L, Fazio S. Home pharmacological therapy in early COVID-19 to prevent hospitalization and reduce mortality: Time for a suitable proposal. Basic Clin Pharmacol Toxicol. 2022 Feb;130(2):225-239. doi: 10.1111/bcpt.13690. Epub 2021 Dec 02. PMID: 34811895.
Copy Download .nbib Format: NLM
Showing 901 to 908 of 908 entries